Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AZN
NVO
Add up to 3 more stocks
AZN
AstraZeneca PLC
-1.18%
$161.85-1.93Delayed quote: Sep 15, 2026, 4:00 PM EDT
Market Cap
$251.01B
52W Range
$145.80 - $212.71
NVO
Novo Nordisk A/S
-2.12%
$42.53-0.92Delayed quote: Sep 15, 2026, 4:00 PM EDT
Market Cap
$188.86B
52W Range
$35.12 - $64.16
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 24.30 | 10.48 |
| Forward P/E | 15.80 | N/A |
| P/B Ratio | 5.00 | 5.60 |
| P/S Ratio | 4.09 | 3.70 |
| P/FCF Ratio | 28.72 | 25.35 |
| EV/EBITDA | 13.69 | 7.76 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 81.9% | 80.6% |
| Operating Margin | 22.8% | 43.1% |
| Net Margin | 17.0% | 35.3% |
| ROE | 20.8% | 53.5% |
| ROA | 9.0% | 19.9% |
| ROIC | 12.8% | 30.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.89 | 0.87 |
| Quick Ratio | 0.67 | 0.66 |
| Debt/Equity | 0.64 | 0.63 |
| Interest Coverage | 8.11 | 30.34 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.0% | 4.2% |
| Payout Ratio | 48.5% | 44.3% |
| Yrs of Dividend Growth | 2 | 6 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.